Dithiotreitol pre-treatment of synovial fluid samples improves microbiological counts in peri-prosthetic joint

Lorenzo Drago1, Delia Romanò2, Andrea Fidanza3,4

  • 1Clinical Microbiology, Department of Biomedical Sciences for Health, University of Milan, Milan, Italy.

International Orthopaedics
|February 22, 2023
PubMed
Abstract

Insights

Dithiothreitol (DTT) pre-treatment of synovial fluid improves bacterial detection in periprosthetic joint infections. This enhanced antibiofilm method increases diagnostic sensitivity for early-stage PJI detection.

Area of Science:

  • Orthopedics
  • Microbiology
  • Infectious Diseases

Background:

  • Periprosthetic joint infections (PJI) pose a significant challenge in orthopedic surgery.
  • Bacterial biofilms in synovial fluid can hinder accurate microbiological diagnosis of PJI.

Purpose of the Study:

  • To evaluate the efficacy of dithiotreitol (DTT) as an antibiofilm pre-treatment for synovial fluid.
  • To determine if DTT pre-treatment enhances bacterial detection and improves early diagnosis of PJI.

Main Methods:

  • Synovial fluid samples from 57 patients with suspected PJI were divided into two groups.
  • One group was pre-treated with DTT, the other with normal saline.
  • Microbial cultures were performed, and bacterial counts and diagnostic sensitivity were compared.

Main Results:

  • DTT pre-treatment significantly increased the number of positive cultures (27 vs 19).
  • Diagnostic sensitivity improved from 54.3% to 77.1% with DTT.
  • Colony-forming unit counts increased significantly from 1884 ± 2129 to 20442 ± 19270 CFU/mL (P=0.02).

Conclusions:

  • DTT pre-treatment is effective in increasing the sensitivity of microbiological examination of synovial fluid in PJI.
  • This method may improve the early diagnosis of PJI by overcoming biofilm limitations.
  • Further studies are needed to confirm these findings and their impact on routine diagnostics.

Related Concept Videos